CardioCell begins 2 heart stem cell trials – U-T San Diego
|
CardioCell begins 2 heart stem cell trials
U-T San Diego CardioCell has begun two new clinical trials of its stem cell treatment for recent heart attack patients, the San Diego company said Wednesday. A Phase 3 trial has started in Kazakhstan and a Phase 2a trial in the United States, said privately held … New San Diego Biotech Charts Stem–Cell Therapies for Heart DiseaseXconomy CardioCell AMI Therapy Trials Launch in U.S., KazakhstanDrug Discovery & Development Stemedica’s CardioCell launches two new clinical trialsSan Diego Source (subscription) |
